Main menu

London Calling 2023: Targeted nanopore sequencing using hybridisation probes reveals immune escape polymorphisms in malaria vaccine candidates


Pathogen populations exposed to host immunity acquire and maintain variation in surface proteins to escape immune responses and contribute to the incomplete efficacy of vaccines. The malaria parasite, Plasmodium falciparum is responsible for over 600,000 deaths and over 400 million clinical episodes of malaria each year. To investigate variation in P. falciparum antigen genes being investigated as vaccine candidates, we developed a nanopore sequencing approach using custom hybridisation probes and an automated haplotype-aware single nucleotide variant (SNV) calling pipeline. This method was applied to investigate SNVs associated with immune escape by sequencing 34 antigen genes in a cohort of children from malaria-endemic areas of Papua New Guinea. Blood-stage antigens were more likely to contain immune-escape polymorphisms than antigens expressed in other lifecycle stages. Identification of these SNVs, associated haplotypes and their prevalence allows recommendations for the formulation of the next generation of P. falciparum vaccines based on diverse antigens.

Authors: Alyssa Barry

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

纳米孔技术

订阅 Nanopore 更新 资源库及发表刊物 什么是 Nanopore 社区

关于 Oxford Nanopore

新闻 公司历程 可持续发展 领导团队 媒体资源和联系方式 投资者 合作者 在 Oxford Nanopore 工作 职位空缺 商业信息 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Chinese flag